ISPOR–THE PROFESSIONAL SOCIETY FOR HEALTH ECONOM..

ISPOR Europe 2025

 

9 - 12 November Glasgow
Close
N. Poster
Poster title
Applicant name
Status
  2-RWD A Hierarchical Algorithm to Identify Pregnancy Start and Duration Using Structured EHR Data Sunny Guin Received Received
  2-IC Evaluating the cost of telemonitoring in cardiology from a service provider´s perspective: a case study from Northern Italy Paolo Candio Received Received
  2-PCR A Collection Of Essays on Patient Centricity in Intervention Development Matthew Reaney Received Received
  3-CO A Systematic Literature Review and Network Meta-Analysis of Once-weekly Icosema With Daily Fixeddose Combinations of Basal Insulin and GLP-1 RA in Patients With Type 2 Diabetes After 52 Weeks of Treatment Lauren Rengger Received Received
  4-HSD Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK Darren Johnson Received Received
  4-EE A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy Jessica Matuoka Received Received
  4-MSR A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data Ashwin Rai Received Received
  5-HSD AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicentre Real-World Study (2019-2024) Thibaut Vergnol Received Received
  5-RWD A Real-World Survey of Healthcare Resource Utilization Treatment Usage and Unmet Need for Haemophilia Patients in Spain Sheena Thakkar Received Received
  5-HPR A Comparative Analysis of Similarities and Differences of RWE Standards Across Regulatory and Health Technology Assessment Bodies Viviana Hernandez Received Received
  5-SA A Systematic Literature Review on Economic Evaluations and Cost-Effectiveness of Second-Line Treatment Options for Immune Thrombocytopenia Isabelle Lundqvist Received Received
  6-PCR A Methodological Review of WOMAC to EQ-5D Mapping Algorithms in Knee Osteoarthritis Ines Guerra Received Received
  6-MSR A Multistate Framework for Analyzing Outcomes in Diffuse Large B-cell Lymphoma With Autologous Hematopoietic Stem Cell Transplant Colleen Dumont Received Received
  7-EPH A Real-World Survey of Health Inequalities As Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia Sheena Thakkar Received Received
  7-PT The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition Joshua Roth Received Received
  8-HTA A Long and Winding Road: An Evaluation of NICE HST Appraisals Taking Longer Than Two Years for Guidance Publication Bersabhe Solomon Received Received
  9-EE A Cost-Effectiveness Analysis of Abrocitinib Versus Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis Gulraj Matharu Received Received
  9-RWD Advanced Therapies and the Unmet Need in Systemic Lupus Erythematosus Patients Results From a Real-World Study in the United States and Germany Victoria Barton Received Received
  10-CO Analysis of Pooled Real-World Utilization and Outcomes Data of rVIII-SingleChain Compared With Standard and Extended Half-Life FVIII Products for Prophylaxis of Haemophilia A in France, Germany, and Italy Korinna Karampampa Received Received
  10-MSR A Two-Stage Bayesian Approach for Real-World Cost-Effectiveness Analysis: Combining Inverse Probability Weighting With Gamma-Beta Regression Model Gian Luca Di Tanna Received Received
  11-PCR A Systematic Review of Trends From Migraine Preference Studies Natasha Ramachandran Received Received
  11-MT Cost Analysis of the Extravascular Implantable Cardioverter-Defibrillator Compared to the Subcutaneous System in Patients at Risk of Sudden Cardiac Death in Italy FRANCESCA MARIANI Received Received
  12-CO APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes Kirsten Herrmann Received Received
  13-RWD AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada Deirdre Weymann Received Received
  13-HTA A Review of Cost Comparisons Submitted to NICE Since the Introduction of the Proportional Approach to Technology Appraisal Alasdair Henry Received Received
  14-EPH Analysis of a Cancer Profile of 10 European States Krzysztof Nojszewski Received Received
  14-MT DIGITAL THERAPEUTICS IN EUROPE: A STRUCTURED REVIEW OF REIMBURSEMENT AND ACCESS PATHWAYS Alison Howell Received Received
  15-MT Environmental Impact of Prefilled and Reusable Injectable Systems: A Systematic Review Matthias Borms Received Received
  15-RWD Airpollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern? Tulio Sarmento Received Received
  16-MSR Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models Emanuel Krebs Received Received
  17-EE A Cost-Utility Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in the UK Antonio Ramirez de Arellano Received Received
  17-PT Reconsidering Generic Utilities: Implications for Equitable Health Technology Appraisal Colleen Dumont Received Received
  18-MSR AI Assistant Meets Human: Refining Methods for Research-Taiilored AI Assistants to Support Global Product Strategy, Decision-Making, and HEOR Impact Katelyn Keyloun Received Received
  18-RWD Archival Sample Testing for Real-World Insights: Innovative Approaches to Enriching Retrospective Studies With Biomarker Data Laura Girardat-Rotar Received Received
  19-EE A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire Christopher Miller Received Received
  19-MT From Workshops to a Dashboard Prototype: Evaluating a Checklist Approach and User Design for Digital Health Technology Assessment Gurmit Sandhu Received Received
  19-HTA Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child Geoffroy Coteur Received Received
  20-PCR Are You Implementation Ready? An Alternative Patient And Healthcare System-Centered Model For Pharma Rita Freitas Received Received
  20-MSR AI Powered SQL for Real-World Data: From Questions to Insights Vasileios Kontonis Received Received
  21-MT Generative A-Powered Extraction of Immunerelated Adverse Events From Oncology Case Reports Colleen Dumont Received Received
  21-PT Can Generative AI Deliver Patientfriendly Summaries? A Case Study Using NICE Guidance for Spinal Muscular Atrophy Colleen Dumont Received Received
  22-HSD Characteristics and Treatment of Prevalent Heart Failure in the US: A Cross-Sectional Analysis of Annual Trends From 20142023 Rachel Knapp Received Received
  22-MSR AI-Assisted Time-to-Event Projection: A Case Study and Broader Potential Jack Ishak Received Received
  23-HTA Addressing Payer Concerns: Opportunities for HEOR in Orphan Drug Development Weiwei Xu Received Received
  24-HSD Clinical Characteristics Among Patients Screening for Hepatitis C Virus (HCV) and HCV Positivity Rates, 2020-2024: Analysis of US Real-World Data Janna Manjelievskaia Received Received
  25-HTA Advancing a Greener Ecosystem in Health Technology Assessment: A Review of Environmental Integration As an Additional Value Driver Colleen Dumont Received Received
  25-PT Systems-level Modelling Approaches for Complex Health Technologies: A Systematic Review Bora Zwart Received Received
  25-EE A Novel View on the Treatment Costs of Relapsed or Refractory Diffuse Large B-cell Lymphoma From the Brazilian Private Healthcare System Perspective: A First- to Third-Line Analysis Frederico Sallum Received Received
  25-CO Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-week Mirikizumab Induction: Real-World Data From IBD BioResource John Downey Received Received
  26-MSR An Update on the Evolving Use of Artificial intelligence and Machine Learning (AI/ML) in Systematic Literature Reviews (SLRs) Ines Guerra Received Received
  28-MT Impact of RFID-Enabled Unit-level Traceability on Resource Utilization and Quality Assurance in Prefilled Syringe Production Matthias Borms Received Received
  28-PT Crossvalidation of the Glycated Haemoglobin Hba1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs Gina Bloomfield Received Received
  28-MSR Anchors Away: Navigating Unanchored Indirect Comparisons With Multi-Level Unanchored Meta-Regression (ML-UMR) Conor Chandler Received Received
  30-PCR Beyond the Conversation: A Narrative Review of Cost-Informed Shared Decision-Making and Its Impact on Medication Adherence in Chronic Conditions Sultan Alshurbaji Received Received
  30-SA Designing Digital Healthcare Professional Surveys: A Methodological Overview Sally Vincent Received Received
  30-PT An Exploration of Implementing Herd Immunity Into Static Models for Economic Evaluation of Vaccines Ruth Chapman Received Received
  32-HSD Describing the Real-World Burden of Demodex Blepharitis: A Multicentre Audit in a UK Public Specialist Eye Care Setting Kate Monk Received Received
  33-EPH Burden of Bloodstream Infections in the United States: Incidence and Healthcare Resource Utilization 2022-2024 Ning Rosenthal Received Received
  33-CO Bridging the Regulatory-Payer Evidence Gap: A Case Study With Six Minute Walk Distance and Mortality Noemi Hummel Received Received
  34-EE A Systematic Literature Review on Costs and Healthcare Resource Utilization in Spinal Muscular Atrophy Michel Kroes Received Received
  34-RWD Clinical Outcomes and Economic Burden of Acute Lower Respiratory Tract Infectionrelated Hospitalizations Among Adults in the United States Post COVID-19 Pandemic Ning Rosenthal Received Received
  34-PCR Burden of Transfusion in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Results From a Real-World Study in European Countries Anggie Wiyani Received Received
  34-MSR Artificial Intelligence Detection of National Clinical Practice Gaps in Hormone Sensitive Prostate Cancer HSPC in Brazil: A Patient-Centered Framework Ming Xuan Lim Received Received
  34-HPR Barriers and Policy Solutions in Off-Patent Drug Repurposing: A Full-Life-Cycle Perspective Jaime Espin Received Received
  35-RWD Clinical Relevance of a Machine Learning Model for Automated Analyses of Depression Severity: The ePHQ-9 in Treatment-Resistant Depression Jodi Silva Received Received
  35-HPR Benefits and Challenges in the Implementation of EU HTAR for Medical Devices: Lessons Learned From the Pharmaceutical Industry Xuanqi Pan Received Received
  35-CO Burden of Illness Among Patients With Transfusion Dependent Beta-Thalassemia in Spain: A Registry-Based Study Shana Malinski Received Received
  35-EPH Cardiovascular Event Rate and Mortality Among Primary Prevention Hypercholesterolemia Patients in Japan Tomohiro Kondo Received Received
  36-HTA Application of Budget Impact Model in Evaluation of P2p Payment Strategy in US Health Systems Ashoke Bose Received Received
  36-EPH Cardiovascular Event Rates and Mortality Among Secondary Prevention Hypercholesterolemia Patients in Japan Tomohiro Kondo Received Received
  37-MT Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting Elisa Tacconi Received Received
  38-EPH Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023 Axel Boehnke Received Received
  38-HSD Economic Burden and Healthcare Resource Utilization of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany: A Claims Data Analysis Yestle Kim Received Received
  38-SA Enhancing Targeted Literature Reviews (TLRs) with Artificial Intelligence (AI): A Methodological Approach for Conducting Efficient Targeted Searches Caroline von Wilamowitz-Moellendorff Received Received
  38-PCR Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey Raymond Milan Received Received
  39-MSR Assessing Bias in LLM-Extracted Real-World Data: A Health Equity Analysis of Access to Care and Outcomes in Metastatic Breast Cancer Darren Johnson Received Received
  41-RWD Comparing the Addition of Natural Language Processing (NLP) to US Electronic Health Records (HER): Insights Into Extracting Predicted Forced Vital Capacity Ppfvc From Unstructured Clinical Notes Janna Manjelievskaia Received Received
  41-SA Factors Associated With the Publication of Real-World Evidence Studies in Lung Cancer by Journal Impact Factor Elizabeth Harvey Received Received
  42-SA Feasibility Assessment of a Real-World Comparator Cohort Using Multiple Qualifying Index Lines of Therapy (LOTs) in Third-line or Later (3L+) Diffuse Large B-cell Lymphoma (DLBCL) Michael Wallington Received Received
  42-MSR Automating PICOs Criteria Assessment in Systematic Reviews With LLMs: Insights From Two Case Studies Ines Guerra Received Received
  42-MT The Unique Value of Detecting Preeclampsia: Comparing Health Economic Analyses of Novel Diagnostics With the ISPOR Value Flower Gareth Obery Received Received
  42-HTA Artificial Intelligence in Pharmaceutical Payer Decision Making- Assessing Current Use, Strategic Intent, and Infrastructure Readiness Rahael Maladwala Received Received
  43-CO Clinical Burden and Transfusionrelated Outcomes in Transfusion-dependent Thalassemia in the Kingdom of Saudi Arabia and United Arab Emirates Vanessa Shih Received Received
  43-EPH Characterizing Polycystic Ovary Syndrome (PCOS) and Related Diagnoses Using a Large US Electronic Health Records Database Linked to Claims, 2020-2025 Janna Manjelievskaia Received Received
  43-HTA Artificial Intelligence-based Population, Intervention, Comparator, and Outcome (PICO) Prediction for European Union (EU) Joint Clinical Assessment (JCA) Gavin Outteridge Received Received
  44-PCR CKDL5 Deficiency Disorder: Caregiver´s Perception of Clinical Symptoms Disease Management and Its Impact on Quality-of-life Ficara Valentine Received Received
  44-CO Clinical Effectiveness and Safety of Second-Line Therapies for Immune Thrombocytopenia (ITP): A Systematic Literature Review Isabelle Lundqvist Received Received
  44-EE All-Cause Healthcare Resource Use in Recurrent Respiratory Papillomatosis: A Claims-based Comparison With Matched Controls Barkha Patel Received Received
  46-HTA Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Sub-analysis of a Pan-European Multidisciplinary Multi-Criteria Decision Analysis (MCDA) Sandra Merino-Montero Received Received
  47-MSR BHM and BHM-Based Extrapolations in an HTA Framework Katrin Haeussler Received Received
  48-PCR Common Criticism of Patient-Reported Outcomes (PRO) in Health Technology Assessments (HTA) by the Institute for Quality and Efficiency in Health Care (IQWiG) in Breast Cancer and Non-Small Cell Lung Cancer (NSCLC) Jenya Antonova Received Received
  50-CO Clinical Profile of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated With Complement Inhibitors: Results From a Real-World Study Anggie Wiyani Received Received
  51-HPR Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany´s DIGA MINJEONG JO Received Received
  53-MSR Can Generative Artificial Intelligence (GenAI) Be Leveraged to Automate Scoping Searches of Systematic Literature Reviews (SLRs)? Ines Guerra Received Received
  53-HTA Beyond Productivity: How Professional Identity Shapes Generative AI Adoption Among Medical Writing Professionals Pia Cuk Received Received
  53-EE Early Outpatient Follow-Up and reduced Health Care Resource Utilization in Acute Heart Failure in Germany: A descriptive Analysis Thomas Staab Received Received
  54-SA Indirect Comparison of Tarlatamab vs. Chemotherapy (CTx) in Patients With Previously Treated, Platinum-Refractory, or Resistant Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Franziska Dirnberger Received Received
  56-HTA Beyond the Surface: Health Technology Assessment and Reimbursement for Inflammatory or Autoimmune Disorders With Cosmetic and Dermatological Manifestations Heather Cameron Received Received
  56-CO Comparative Efficacy of Asciminib Versus Second Generation TKIs in Newly Diagnosed Phcml Using Unanchored Matching-Adjusted Indirect Comparisons Isabelle Lundqvist Received Received
  56-PCR Describing the Burden of RSV Infection and Subsequent Wheezing in Toddlers: An International Cross-Sectional Study Ficara Valentine Received Received
  57-RWD Design Operating Characteristics in a Non-Interventional Study Framework Charlotte Wilhelm-Benartzi Received Received
  58-PCR Development of a Content-Valid Patient-Reported Outcome (PRO) Measure for Adults With Glycogen Storage Disease Type 1a (GSD1a): The GSD1a Symptom Diary-Adult Version Ufuk Coskun Received Received
  58-CO Comparative Efficacy of Iptacopan Monotherapy Vs Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC) Anggie Wiyani Received Received
  58-EE Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France Costello Medical Received Received
  59-PCR Development of a Discrete Choice Experiment Survey to Assess Patient Preferences for Treatment of Metastatic Breast Cancer Jessica Nicholson Received Received
  59-MSR Comparing Key European HTA Body Methodological Standards for Systematic Reviews of Economic and Utility Evidence Yogesh Punekar Received Received
  59-CO Comparative Efficacy Safety and Discontinuation of Inhaled Levodopa for Patients With Parkinson´s Disease: A Network Meta-Analysis Kate Monk Received Received
  59-SA Laboratory Testing Patterns in Patients With Breast Cancer Treated With CDK4/6 Inhibitors: A Multi-Country Electronic Health Record Study From the UK Germany and Japan Darren Johnson Received Received
  60-RWD Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries´ Data Quality Mai Duong Received Received
  62-PCR Development of the Adelphi Caregiver Experience Questionnaire© (ACARE): A Novel Tool Designed to Measure and Understand the Burden and Quality of Life Impacts of the Caregiver Role Gavin Dickie Received Received
  65-HSD Investing in Diagnosis: Health Economic Value of Early Obstructive Sleep Apnea Detection for Private Insurers in India Ankit Ghildiyal Received Received
  65-EPH Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis Lauren Rengger Received Received
  65-PCR Diagnostic Odyssey of Patients With the Rare Immunodeficiency Activated Pi3 Kinase Delta Syndrome APDS: Case Study With Expert Interviews and Patient Surveys Roman Spelsberg Received Received
  66-RWD Disease Severity at Advanced Therapy Initiation in Real-World Psoriasis Patients in the US Jodi Silva Received Received
  66-HSD Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review Andrew Kwist Received Received
  67-EE Assessment Of Health State Utilities Associated With Treatment For Chronic Hepatitis B Virus HBV Infection Louis Matza Received Received
  67-PCR Effectiveness of Vonoprazan on Health-Related Quality of Life and Sleep Quality in Chinese Patients With Reflux Esophagitis: Post Hoc Analysis of the VIEW Study Fang Zhou Received Received
  68-HTA Challenges and Opportunities in the Dutch Lock Procedure Improving Access and Reimbursement Timelines for Cell and Gene Therapies in the Netherlands Angela Borghouts- de Ruijter Received Received
  71-HPR Estimating Lost Life-years and Quality-Adjusted Life-years of Undertreatment of Patients With Renal Cell Carcinoma and Metastatic Pancreatic Cancer in England Vladislav Berdunov Received Received
  73-HTA Challenges in the German AMNOG Procedure: The Need for National PICO Transparency and Optimized Consultation Windows in the Context of EU-HTA Hanna Bayer Received Received
  74-CO Dinutuximab Beta Versus Historical Controls in the Maintenance Therapy of Relapsed Neuroblastoma: Unadjusted and Adjusted Indirect Comparison Fabian Schmidt Received Received
  74-EE Bimekizumab Cost per Responder Analysis Compared to Other Licensed Interleukin Inhibitors at Week 52 for the Treatment of Psoriatic Arthritis: A United Kingdom Perspective Ezinne Byrne Received Received
  75-PCR Enhancing Understanding of Quality of Life in Multiple Sclerosis Through Social Listening: Complementing Traditional HRQoL Measures Jackie Cuyvers Received Received
  75-MSR AI Time and Motion - Analysis of the Accuracy and Efficiency of AI for HTA-Standard SLRs Kate Monk Received Received
  75-CO Disease Progression Modelling for an Ultra-Rare Disease: Lysosomal Acid Lipase Deficiency (LAL-D) Sandra Merino-Montero Received Received
  76-HSD Modelling the Environmental and Cost Impact of a Novel Detergent in NHS Endoscope Reprocessing Workflows mutsa mutowo Received Received
  77-HSD Number of Inquiries for a Second Course of Teprotumumab in the US Over Four Years Alexandra Eddy Received Received
  77-HTA Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems EUNKYEONG BAE Received Received
  78-PCR Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study Irina Proskorovsky Received Received
  79-CO Early Change in Proteinuria as a Surrogate Endpoint in Studies of IgA Nephropathy: An Updated Patient-Level Meta-Analysis and Discussion of Appropriate Methodology Barnaby Hunt Received Received
  79-HSD Optimizing Workforce Efficiency and Reducing Waiting Lists Through Remote Monitoring in Obstructive Sleep Apnea (OSA) Care in NHS Ankit Ghildiyal Received Received
  80-SA Real-World Cancer Treatments for Common Solid Tumors in China: A Targeted Literature Review Mireia Raluy Callado Received Received
  81-HTA Comparing Clinical Benefit Criteria in Health Technology Assessment of Oncology Drugs in the Netherlands and Europe: Driving Real Value or Inequal Access? Colleen Dumont Received Received
  81-HSD Overcoming Patient Access Barriers in Complex Conditions: Lessons From Schizophrenia for Broader Healthcare Applications Bregt Kappelhoff Received Received
  81-HPR Evolution of National Price Negotiations for Pharmacy/Retail Medicines (Triparty Negotiations) in Sweden and Implications for Access Anja Wikström Received Received
  81-MSR Effect of Positive Airway Pressure Therapy on Mortality in European Obstructive Sleep Apnea Patients: Post Hoc Analysis of a Global Meta-Analysis Ankit Ghildiyal Received Received
  82-RWD Expediting Oncology Evidence Generation by Leveraging Emrenabled Clinically-rich Real-World Data at Scale Laura Girardat-Rotar Received Received
  84-RWD Feasibility Assessment of Real-World Data for Trial Emulations: A Methodological Framework Colleen Dumont Received Received
  85-HTA Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets? Nikhil Taxak Received Received
  85-EPH Estimating Rare Disease Incidence and Prevalence of Essential Thrombocythemia in Major Health Plans in the United States Noemi Hummel Received Received
  86-MSR Ensuring Patient Inclusion When Baseline Is Missing: Utilizing Constrained Longitudinal Data Analysis Clda for Patient Reported Outcomes (PROs) Hannah Fairbanks Received Received
  86-RWD From Clinic to Cohort: The VOICE Vitiligo Registry and Bioresource As a Blueprint for High-Fidelity Specialist Registries Charlotte Curtis Received Received
  88-HTA Confidential Prices in NICE Health Technology Assessment: How Common Are They? Sarah Wilkes Received Received
  88-EPH Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study Ugne Sabale Received Received
  88-PCR Explaining Psychiatric Co-morbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact Allison FitzGerald Received Received
  88-CO Effectiveness of Subcutaneous Natalizumab in Multiple Sclerosis: Real-World Evidence From a Finnish Registry Study Peter Oliver-Smith Received Received
  89-CO Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pre-treated Breast Cancer: A Systematic Literature Review (SLR) Patricia Dorling Received Received
  89-HTA CONITEC in Action: A Trend Analysis of Conitec´s Evaluation Outcomes From 2020 to Present Day Dominika Meszarosova Received Received
  90-CO Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in pre-treated locally advanced/metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR) Patricia Dorling Received Received
  92-EE Budget Impact Analysis of Obecabtagene Autoleucel for Adults With Relapsed/Refractory B-cell ALL From a US Payer Perspective David Bertwistle Received Received
  92-HTA Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAI) and Ventilatorassociatedhospitalacquired Pneumonia (HAP/VAP) Caused by Suspected MBL-producing Enterobacte Sheng-Tzu Hung Received Received
  93-SA The Health Economic Case for AI in Radiology: A Systematic Review and Appraisal of Evaluation Quality and Methods Lucy Gregory Received Received
  94-RWD Healthcare Resource Utilization Associated With Acute Pancreatitis in Patients With Familial Chylomicronemia Syndrome Treated With Olezarsen: A Post Hoc Analysis of Balance Study Data Weiying Wang Received Received
  94-PCR Exploring the Promise of Generative AI for Coding and analyzing Qualitative Patient Data: Results From a Pilot Study in Non-Hodgkin´s Lymphoma Karen Bailey Received Received
  95-EPH Evaluation of Safety Signal Management in Europe: Insights From PRAC Reports (2016-2024) Colleen Dumont Received Received
  95-HTA Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages Sheng-Tzu Hung Received Received
  95-HPR Financial Impact of EU MDR Compliance: A Cost Mapping Assessment for Manufacturers Aleksandra Kozlova Received Received
  96-HPR Fit-for-purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework Darren Johnson Received Received
  97-HTA Cost-Effectiveness Modelling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions Chloi Theriou Received Received
  100-CO EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial Irina Proskorovsky Received Received
  101-RWD Improving Data Quality in Oncology Electronic Health Record (HER)-Derived Databases for Research and Regulatory Decision-Making Zhaohui Su Received Received
  101-SA Using a Large Language Model LLM for Data Extraction of Studies: Learnings From a Targeted Literature Review TLR in Non-Small Cell Lung Cancer (NSCLC) Caroline von Wilamowitz-Moellendorff Received Received
  102-CO Estimating the Mean Time in Treatment Free Remission for Patients in Early Line CML Isabelle Lundqvist Received Received
  103-HTA Defining Unavoidable Uncertainty in HTA: Towards More Flexible and Adapted Approaches for Promising Treatments Dimitri Pouradier Duteil Received Received
  103-MSR Exploring Meaningful Change in Digital Health Technologies via Qualitative Interviews Elizabeth Collins Received Received
  103-HSD Standardizing Point-of-care mRNA-Based Gene Therapy Production in Europe: A Cost and Capacity Analysis of the Nanospresso Platform Maura Leusder Received Received
  104-MSR Exploring Non-Proportional Hazards Multi-Level Network Meta-Regression (ML-NMR) for Survival Extrapolations in Oncology Chloe Spalding Received Received
  104-PCR Harnessing Digital Patient Monitoring and Primary Care Records to Map the Disease Burden of Multiple Myeloma in the United Kingdom Kim Summers Received Received
  106-SA Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenzainfluenzalikeillness: A Systematic Literature Review Jingyan Yang Received Received
  108-HPR Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future Nikhil Taxak Received Received
  110-EE Budget Impact of Metyrapone for the Treatment of Cushing´s Syndrome in France Mariam SBEITY Received Received
  110-RWD Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations Benjamin Ackerman Received Received
  111-PCR Healthcare Professionals-Perceived Benefits and Opportunities to Improve an Electronic Patient Reported Outcomes (ePRO) Based Remote Symptom Monitoring (RSM) Program During Cancer Treatment Renae Neumann Received Received
  111-EPH Five Year Inpatient Hospital Trends of COVID-19 Admissions in US Medicare Fee for Service peter kardel Received Received
  112-HPR Health Halo Effect in Supplement Marketing: A Content Analysis of Medical Claims in Community Pharmacies Marwan Alrasheed Received Received
  113-RWD Landscape of Natural Language Processing (NLP) Capabilities at Clinical Sites: Insights From a Real-World RW Gastric Cancer (GC) Study Julia Gallinaro Received Received
  114-EPH Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States Alison Isherwood Received Received
  115-PCR Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan Jade Garratt-Wheeldon Received Received
  116-RWD Leveraging a Multi-Country Real-World Data Observatory to Monitor Respiratory Tract Infections and Evaluate Public Health Interventions in Europe Jasper Deuring Received Received
  116-PCR Health-Related Quality of Life in First-Line Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review With Focus on the PD-L1 Negative Subgroup Colleen Dumont Received Received
  118-RWD Leveraging Large-Language Models for Medical Code List Creation: An Example Using the Charlson Comorbidity Index Andreas Ochs Received Received
  118-EE Burden of Illness and Healthcare Resource Utilization Among Patients Newly Diagnosed With Amyotrophic Lateral Sclerosis in the United States: A Retrospective, Observational, Cohort Design Study Chiranjit Ghosh Received Received
  118-HSD Trends in Receipt of Preventive Healthcare Services from 2020-2024: US Electronic Health Records (EHR) Database Analysis of 118 Million Patients Janna Manjelievskaia Received Received
  119-HSD Understanding Trends and Opinions on More Environmentally-friendly Health Care: A Clinician Survey Kinga Marczell Received Received
  120-HTA Economic Assessments of Rare Disease Drugs in France: Insights From CEESP Opinions Reviews Colleen Dumont Received Received
  123-HPR Innovation in Off-Patent Competitive Environment: Key Learnings From Successes and Failures Richard Mee Received Received
  125-CO Garbage In, Garbage Out: Can AI Reduce the Impact of Human Error in eCOA Localized Text Migration? Jonathan Norman Received Received
  125-RWD Millennial Medical Record Data Profile: A Japanese Electronic Medical Records Database Utilising Unstructured Data for Lung Cancer Research Ayumi Hamaguchi Received Received
  126-MSR Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering Ashwin Rai Received Received
  126-PCR Identifying Patient-Reported Outcome Measures to Capture Patients´ Experiences of Symptoms and Impacts of Acute Myeloid Leukaemia (AML) Isabelle Petit-Delattre Received Received
  126-EPH Higher Mortality for Generalized Pustular Psoriasis Compared With Plaque Psoriasis Highlights the Need for Improved Treatments: Insights From a Meta-Analysis Helen Miller Received Received
  127-PCR Identifying Patient-Reported Outcome Measures to Capture Patients´ Experiences of Symptoms and Impacts of Myelodysplastic Syndromes (MDS) Isabelle Petit-Delattre Received Received
  127-MSR Implementing Simultaneous Maximum Acceptable Risk Thresholds (SMARTs) in Discrete Choice Experiments (DCE): A Feasible Approach to Quantify Tolerance for Multiple Risks Natalie Land Received Received
  129-RWD Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018 2022 Levina Chandra Khoe Received Received
  129-CO Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study Nicole Carroll Received Received
  130-EPH Hospitalizations for Myasthenia Gravis: Pre- and Post-COVID Trends Naomi Sacks Received Received
  130-EE Clinical and Economic Impact of Early Treatment in Relapsing Remitting Multiple Sclerosis With High Efficacy Disease Modifying Therapy in Mexico Margarita Fuentes Received Received
  130-MSR Improving Indirect Treatment Comparisons via an Alternative MAIC Patient Weighting Method Martin Scott Received Received
  131-PCR Impact of Non-Transfusion-Dependent Thalassemia on Adult Patients´ Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates Vanessa Shih Received Received
  132-HPR Levelling the Field: How the MFN Could Transform Drug Pricing? Rebecca Andrews Received Received
  132-HTA Evaluating High-Cost Gene Therapies for Non-Cancer Conditions: Insights From NICE´s Standard Appraisal Process Naomi Stapleton Received Received
  133-PCR Impact of Transfusion-Dependent Thalassemia on Adult Patients´ Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates Vanessa Shih Received Received
  133-EE Clinical Management and Outcomes of Patients in England With eGFR Mutation Positive Non-Small Cell Lung Cancer: A Retrospective Observational Study and Its Impact on UK Health Technology Assessments Elise Bell Received Received
  133-RWD Parental Vaccine Hesitancy in Children With Co-morbidities: A Comparative Analysis Anar Murphy Received Received
  134-HTA Evaluating the Role of Patient Opinion in NICE Decision-Making for Rare Disease Appraisals: A Review of Committee Papers and Final Guidance Lauren Rengger Received Received
  135-MSR Key Risk Indicators in eCOA: Considerations for Improving eDiary Data Quality and Regulatory Compliance Ingeborg de Gooijer Received Received
  136-HTA Evaluating the Value Elements Considered in Health Technology Assessments of Paroxysmal Nocturnal Hemoglobinuria Treatments: A Targeted Review Anggie Wiyani Received Received
  136-PCR Improving the Conceptual Coverage of the 15-item Penn Parkinson´s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population Laure Delbecque Received Received
  137-MSR Leveraging NLP to Characterize Real-World Triptan Use and Adherence From Unstructured EHR Sunny Guin Received Received
  137-HTA Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals George Bungey Received Received
  138-EPH Important Risk Factors to Proxies of Treatment Failures in Patients With Major Depressive Disorder: Insights From a Claims Database Study Ling Zhang Received Received
  141-EE Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma George Bungey Received Received
  141-HTA Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions Colleen Dumont Received Received
  142-CO Impact of Tafamidis Use in Colombian Patients Diagnosed With ATTR-CM on Health-Related Quality of Life During One Year of Follow-up: Real-World Study in Colombia Juan Manuel Reyes Sanchez Received Received
  142-MSR Machine Learning to Predict Noncompliance and Program Dropout in Patients Treated for Chronic Diseases: Unsupervised and Supervised Analyses From a Large Multi-national Drug Access Program Database Mariana Rodrigues Received Received
  142-EE Comparing the Economic Burden in Patients With versus Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database Janna Manjelievskaia Received Received
  143-MSR Matching Adjusted Indirect Comparison Of Asciminib vs Flumatinib As First-Line Treatment for Chronic Myeloid Leukemia in China Xue Gao Received Received
  143-EE Comparison of Non-Statin Lipid-Lowering Therapies (LLTs) by Their Annual Cost per Effectively Treated Very High-Risk Patient in Spain Vanessa Gómez Navarro Received Received
  143-EPH Incidence of Neutropenia Adverse Events Identified in Electronic Health Care Records Among Initiators of CDK4/6 Inhibitors With Advanced Breast Cancer in the UK Darren Johnson Received Received
  145-EPH Increases in Frailty Following Hospitalization With COVID-19: An Analysis of Claims and Annual Health Check Data Paul McDwyer Received Received
  145-RWD Real-World Insights From the LOGEX IMID Observatory: A Multi-Country, Multi-Year Analysis of Treatment Pathways and Healthcare Resource Utilization in Immune-Mediated Inflammatory Diseases Jasper Deuring Received Received
  147-MSR Methods for Incidence Progression Estimation in Partitioned Survival Analysis: Does the Chosen Method Matter? George Bungey Received Received
  148-PCR Listening to the Voice of the Patient: Insights From a Survey on the Burden of Recurrent Respiratory Papillomatosis in the United States Barkha Patel Received Received
  148-HTA Fractional Polynomial Survival Models in HTA: An Exploratory Review of Use and Methodological Guidance Across Global Agencies Andre Verhoek Received Received
  148-EE Components of the Direct Cost of Topical Treatment for Chronic Wounds in Adults and Elderly: A Systematic Review Ramon Oliveira Received Received
  149-RWD Real-World Burden of Illness in Patients With ER+/HER2- ABC Receiving Second-Line Treatment: Interim Results of Longitudinal Health Utility Data Christian Atkinson Received Received
  150-HTA From Evidence Gaps to Launch Delays: A Review of Health Technology Assessment Critiques and Health Economics and Outcomes Research Strategy Readiness Weiwei Xu Received Received
  150-MSR Modelling Physician Prescribing Decisions Based on Patient Characteristics for Positioning of a Novel Treatment Entering a Well-Established Category Sarah-Jane Cashmore Received Received
  151-PCR Mapping the Evidence on Interrelationships Between Cancer Stage Financial Toxicity (FT) and Health-Related Quality of Life (HRQoL) Ali Tafazzoli Received Received
  152-CO Inefficiencies of Off-Label Therapy in the Prevention of Generalized Pustular Psoriasis (GPP) Flares: Real-World Evidence From Europe Helen Miller Received Received
  152-MSR Natural History of Creutzfeldt-Jakob Disease: A Comparison of Manual Versus Manual Plus AI-Assisted Approaches in Literature Review Setareh Williams Received Received
  153-HPR Orphan Drugs Availability in Israel: A Base for Policy Development Daphna Arbel Received Received
  153-EE Constructing a Dynamic Budget Impact Model: An AI Pre-Training Approach for a New Parkinson´s Disease Drug Nicholas Yulin Chen Received Received
  153-HTA From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe Alexandra Guyenet Received Received
  153-RWD Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions Nadia Quignot Received Received
  154-HTA From JCA to Local PR: Evaluating Impact Across Europe Varol N. Received Received
  155-MSR New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change Allison FitzGerald Received Received
  157-EE Cost and Healthcare Resource Utilisation Associated with Chronic Inducible Urticaria: A Targeted Literature Review Mukhtar Ahmad Dar Received Received
  158-EE Cost Calculator of Immunotherapies in 1L Endometrial Cancer Treatment for the Deficient Mismatch Repair Proficient Mismatch Repair and Intentiontotreat Populations From the Brazilian Private Healthcare System Dipika Morgan Received Received
  158-HTA From Theory to Practice: Guidance for Identifying and Selecting Mapping Algorithms for Health Economic Models George Bungey Received Received
  158-CO Leveraging Generative AI for Efficient Patient Safety Narrative Drafting: A Semaglutide Case Study Colleen Dumont Received Received
  159-PCR Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Non-Metastatic Cancer: A Claims-based Analysis Ali Tafazzoli Received Received
  159-EE Cost Comparison of Symptom Treatment in Atopic Dermatitis Using Upadacitinib and Dupilumab in Poland Karolina Dziadek Received Received
  159-RWD Real-World Insights Into Breast Cancer in the UK: Findings From UK EHR-Derived Data Darren Johnson Received Received
  160-MSR Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements Annett KUCKA Received Received
  160-HPR Healthcare Professionals´´ Views on Implementing Generic and Biosimilar Medicines´ Policies Kefah Alqawasmeh Received Received
  161-RWD Real-World Insights Into Prostate Cancer Management Using Electronic Health Record-Derived Data From the UK Darren Johnson Received Received
  161-HPR Physicians´ Knowledge, Attitude, and Practice Regarding Medical Liability: A Study in Saudi Arabia Mohamed AlQurashi Received Received
  162-HTA German HTA Outcomes for Rare Disease Drugs When EMA Orphan Designation Does Not Legally Determine Added Benefit Daniela Tummoscheit Received Received
  162-HPR Predicting the Maximum Fair Price (MFP) From Medicare Negotiations Louisa Oliver Byrne Received Received
  162-CO Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long Term Prophylaxis in Hereditary Angioedema Amrita Debnath Received Received
  163-CO Matching-Adjusted Indirect Comparison of Obecabtagene Autoleucel Versus Blinatumomab Inotuzumab Ozogamicin and Ponatinib in Relapsed or Refractory Adult B-cell Acute Lymphoblastic Leukaemia David Bertwistle Received Received
  165-EE Cost Effectiveness Analysis of Trizepataide for the Treatment of Type 2 Diabetes Mellitus in Saudi Arabia Ahmed Alghamdi Received Received
  166-MSR Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD) Evangelos Vagianos Received Received
  168-PCR Pain and Fatigue Assessment and Evaluation in Oncology Trials Paul Cordero Received Received
  169-EPH Negative Symptoms in Schizophrenia: An Observational Study of Patient Characteristics Cost and Healthcare Resource Utilization From a US Healthcare Database Jing Zhao Received Received
  169-CO Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line 2L+ Treatments in Extensive Stage Small Cell Lung Cancer ES-SCLC Jingyi Liu Received Received
  170-HTA Have Delays in Vaccine Market Access Improved in Europe and the US Over the Last Decade? Samantha James Received Received
  170-PCR Patient and Societal Preferences for On-Demand Treatment in Hereditary Angioedema: Estimation of Utility Using a Discrete Choice Experiment Latasha Avery Received Received
  172-CO Nutritional Profile and Cost Evaluation of Elderly Patients in Home Care Within the Brazilian Private Health Sector: A Retrospective Study Erica Camargo Received Received
  173-HPR Regulatory Landscape Challenges and Trends in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review Viviana Hernandez Received Received
  173-PCR Patient Perspectives on Disease Experiences and Value of Real-Time Self-Reported Symptom and Treatment Monitoring in Locally Advanced and Metastatic Breast Cancer Ainsley Belisle Received Received
  174-EE Cost Implications of Declining MMR Coverage in England: Modelling NHS Burden and the Value of Catch-Up Vaccination Ruth Chapman Received Received
  174-CO Overall Survival With Second-generation Androgen-Receptor Signaling Inhibitors in Patients With Metastatic Castration Resistant Prostate Cancer: An Umbrella Review Immaculate Nevis Received Received
  175-HTA Health Technology Assessment of Emicizumab for Pediatric Hemophilia A From a Hospital Perspective Bruno Boietti Received Received
  175-PCR Patient Perspectives on the Lifelong Impact of Preterm Birth in Chronic Respiratory Disease Care Valentine Ficara Received Received
  176-PCR Patient Perspectives on Unmet Needs in mCRPC: Emphasizing Improved Quality of Life and Delay in Chemotherapy Valéry Risson Received Received
  177-HTA Healthstate Utilities for Hormone Receptorpositive Hrhuman Epidermal Growth Factor Receptor 2negative HER2 Breast Cancer Alison Davie Received Received
  177-RWD Switching Within vs. Outside the TNFi Class Following TNFi Failure in Patients With Crohn´s Disease (CD) in Europe: A Meta-Analysis of Real-World Outcomes OTTAVIO SECCHI Received Received
  179-RWD The Burden and Management of Flares Among Pregnant Patients With Generalized Pustular Psoriasis (GPP): Real-World Evidence (RWE) From the Global SCRIPTOR Study Helen Miller Received Received
  181-EPH Population Characteristics of a Large, Linked Mother-Child EHR Dataset From Truveta Sunny Guin Received Received
  184-EPH Pre-Diabetes Prevalence and Progression in the UAE: Insights for Early Intervention and Resource Optimization João Carapinha Received Received
  184-HPR Single-Arm Trials and Reimbursement Decision-Making in Europe: A Case Study in Non-Small Cell Lung Cancer Giles Monnickendam Received Received
  184-EE Cost per Responder Analysis of Certolizumab Pegol Versus Adalimumab in Patients With Moderate to Severe Active Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Payer Perspective From France, Germany, Italy, and United Kingdom Ezinne Byrne Received Received
  185-PCR Perspectives of Patients and Caregivers on Relapsed/Refractory Acute Myeloid Leukemia Treatments: A Mixed-Methods Interview Study Paul Cordero Received Received
  186-EPH Premature Cancer Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs Bernadette Pöllinger Received Received
  187-EPH Premature Mortality and Lost Productivity Due to HPV-related Cancers in Europe Ugne Sabale Received Received
  188-EE Cost Trends for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Management in Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) Treatment With Axicabtagene Ciloleucel (Axi-cel) in the US Alexandra Guyenet Received Received
  189-HTA HTA Readiness for Tumor-Agnostic Therapies: Lessons From Analogues Across Major Markets Nikhil Taxak Received Received
  189-HPR Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia Anand Jha Received Received
  192-PCR Productivity Impacts and the Need for Carer Support in Obstructive HCM: A Patient and Carer Survey Michael Hurst Received Received
  195-HTA Impact of the Societal Perspective on HTA Decision-Making in Rare Diseases Kate Monk Received Received
  196-EPH Public Health and Economic Impact of RSVpreF Maternal Vaccination Among Infants in Five Asian Countries Rengina Kefalogianni Received Received
  197-EPH Public Health and Economic Impact of RSVpreF Vaccination Among Older Adults in Latin America and the Caribbean Rengina Kefalogianni Received Received
  202-EE Cost-Effectiveness Analysis of Generalizing Reimbursement the Lp(a) Testing in Secondary Prevention in a Population of French Patients With Cardiovascular Disease victor Vega Received Received
  202-MSR The Statistical Abyss: Real-World Evidence for Health Technology Assessment Martin Scott Received Received
  202-EPH Quantifying the Economic Burden of Undiagnosed Sleep Apnea in India´s Productive Population: A Health Economic Modeling Approach Ankit Ghildiyal Received Received
  202-CO Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients with Type 2 Diabetes: An Observational, Single-Arm, Multicentre, Retrospective Cohort Study (REALISED) Woralak Chumchujan Received Received
  205-CO Real-World Evidence on the Broader Benefits of GLP-1 RA-based Therapies: A Global Targeted Literature Review Katherine Gibbs Received Received
  205-HTA Integrating Health Equity Into Health Technology Assessment: A Scoping Review Haneen Aljamal Received Received
  205-MSR Transportability of Overall Survival Estimates From the United States to Germany in eGFR+ Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment Colleen Dumont Received Received
  205-EE Cost-Effectiveness Analysis of Inhaled Levodopa for Managing OFF Episodes in Patients With Parkinson´s Disease Kate Monk Received Received
  205-PCR Real-World Drivers of Adherence in Obesity Highlight the Need for Patient-Centered Interventions Andrea Leith Received Received
  207-HPR The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance Tracey Tingle Received Received
  208-MSR Uncovering Patient Narratives of Opioid Use and Recovery Using Large Language Models for Topic and Emotion Analysis of Social Media Discussions Ashwin Rai Received Received
  211-EPH SEPTAL MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM a Real-World STUDY Ana Paula Casagrande Drozda Oliveira Received Received
  213-MSR Use of Multi-Level Network Meta Regression (ML-NMR) Model in RET Mutationpositive Medullary Thyroid Cancer (MTC) Min-Hua Jen Received Received
  213-CO Review of Index Line Selection Methods in Hemato-oncology Externally Controlled Trials: A Secondary Analysis of the Hermans Et Al Systematic Review Michael Wallington Received Received
  214-HPR The Role of Technological Innovation and Policy in the Evolution of Care Models in Italy FRANCESCA MARIANI Received Received
  216-CO Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-negative Breast Cancer (TNBC): Systematic Literature Review (SLR) Patricia Dorling Received Received
  217-MSR Using Propensity Weighting Methods With Real-World Data and Noncontrolled Extension Data From a Clinical Trial to Estimate Long-term Treatment Effect: An Example in Alzheimer´s Disease Marie-Ange Paget Received Received
  218-CO Semaglutide Weight Outcomes Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Real-World Setting Yestle Kim Received Received
  218-HPR Through a Glass Darkly: The What, How, and What Now for Global Net Price Transparency David Carr Received Received
  220-EE Cost-Effectiveness Analysis of Sparsentan for the Treatment of Immunoglobulin a Nephropathy in Spain Antonio Ramirez de Arellano Received Received
  222-HPR Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-offs Jaime Espin Received Received
  223-CO Symptom Relief With Vonoprazan Treatment in Gastroesophageal Reflux Disease Patients With Diabetes in China: Post Hoc Analysis of the VIEW Study Fang Zhou Received Received
  225-PCR The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey Raymond Milan Received Received
  227-HPR Understanding Reimbursement and Access Policies for Immunoglobulins and other Plasma-Derived Medicinal Products Across Europe Marek Kortus Received Received
  227-HTA Mapping Writer-AI Conversations for HTA: An Analysis of 12500 Messages Anton Orell Wiehe Received Received
  229-HTA Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan Kristi Bertzos Received Received
  230-EE Cost-Effectiveness Evaluation of RSVpreF Vaccine for Preventing RSV Among Older Adults With High Risk Under Taiwan National Vaccination Program Sheng-Tzu Hung Received Received
  233-HTA Middle East NICE Move Towards Standardized Health Technology Assessment Dominika Meszarosova Received Received
  237-EE Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilised Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Ireland Mary MacKinnon Received Received
  238-EE Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes George Bungey Received Received
  239-CO The Effect of Nutritional Supplements on Semen Quality and Pregnancy Rates in Patients With Male Factor Infertility: A Systematic Literature Review and Network Meta-Analysis Lauren Rengger Received Received
  240-HPR Who Pays the Price? International Impacts of US Drug Cost Benchmarking Ariel Hammerman Received Received
  242-PCR The Road Ahead: A Qualitative Study Mapping the Experience of Patients With Chronic Kidney Disease Lillian Witting Received Received
  242-HTA Navigating Evidence Requirements for Joint Clinical Assessment (JCA): Practical Considerations for Systematic Literature Review (SLR) and Indirect Treatment Comparisons (ITC) Caroline von Wilamowitz-Moellendorff Received Received
  244-CO The Incidence and Economic Impact of Major Adverse Events Associated with Intravascular Temperature Management: A Systematic Review, Analysis, and Model Timothy Kelly Received Received
  244-HTA Navigating HTA Requirements: The Current Landscape of Alzheimers Disease Modifying Treatments Nathalie Abi-Saleh Received Received
  246-CO The Prevalence of COAs and DHTs for Studying Sleep Disorders in Clinical Trials Deepika Sehijpaul Received Received
  249-HTA Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond Lauren Rengger Received Received
  254-HTA NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance? Charlotte Mitchell Received Received
  255-CO Treatments for Children With Newly Diagnosed Medulloblastoma-A Systematic Review Of Randomized Controlled Trials Lauren Rengger Received Received
  256-EE Cost-Effectiveness of Implementing Spirometry Screening for COPD in Primary Care in Russia Nuriya Musina Received Received
  256-CO UDCA Treatment Response in Primary Biliary Cholangitis in the United States Diane Ito Received Received
  257-CO Understanding Xlh´s Impact: Incorporating Patient Perspectives to Develop a Comprehensive Conceptual Disease Model CDM to Drive Patient Engagement and the Generation of Meaningful Patient Experience Data Laura Meade Received Received
  258-EPH Treatment Patterns in Epithelial Ovarian Cancer (EOC) With a Focus on Recurrent EOC and PARPi Progressors: A Targeted Literature Review Across Selected Countries Aurore BERGAMASCO Received Received
  258-HTA Nutrieconomics: Concept and Expert Consensus on Health Technology Assessment of Nutritional Interventions in Brazil Erica Camargo Received Received
  260-CO Using Natural Language Processing to Identify Sequencing Patterns in Advanced Urothelial Carcinoma : A Real-World Observational Study Thibaut Vergnol Received Received
  260-EE Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach Versus Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile Mary MacKinnon Received Received
  260-PCR Utility Estimates for Healthstates Associated With Immune Thrombocytopenia: A Systematic Literature Review Isabelle Lundqvist Received Received
  261-EE Cost-Effectiveness of Mixedapproach Maternal RSVpreF/Infant Nirsevimab Immunization Versus Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain Mary MacKinnon Received Received
  266-PCR We Hear What You Are Saying: The Design and Development of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centred Outcomes Research Studies Gemma Al-Jassar Received Received
  269-PCR Why Are Patient-reported Outcome Measure (PROM) Results Missing from Labels of Obesity Management Medications? Ana Liberato Received Received
  271-HTA Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis Shivani Shah Received Received
  277-EE Cost-Effectiveness of Strategies to Prevent Respiratory Syncytial Virus Infections Among Infants in Ireland Mary MacKinnon Received Received
  277-EPH Validation Between Antidepressant Treatment Failure Proxy and PHQ-9 Score in Major Depressive Disorder Using a Linked Insurance Claims and Electronic Health Record Dataset Jing Zhao Received Received
  279-HTA Reassessing NICE´s Highly Specialized Technologies (HST) Criteria: A Retrospective Review of Borderline and Approved Appraisals Under the Revised Framework Lauren Rengger Received Received
  279-EPH Years of Life Lost and Productivity Costs Due to Premature Cancerrelated Mortality in Ukraine and in Kiev City, Lviv and Cherkassy Regions Bernadette Pöllinger Received Received
  280-EPH Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco Bernadette Pöllinger Received Received
  286-EE Costs and Healthcare Resource Utilization Associated With Generalised Myasthenia Gravis: A Systematic Literature Review Nicholas Adlard Received Received
  290-EE Costs Associated With the Treatment of Surgical Site Infections in Solid Organ Transplant Recipients: A Scoping Review Ramon Oliveira Received Received
  304-HTA Subsequent Treatments and NICE Appraisals for DLBCL: A Review of Committee Discussions Nate Smith Received Received
  314-HTA The Development of the Multi Criteria Decision Analysis in Specialized Burn Care: The Methodological Process Raaba S.M. Thambithurai Received Received
  316-EE Danicopan a Dominant Option for the Treatment of Patients With Paroxysmal Nocturnal Haemoglobinuria PNH With Residual Haemolytic Anaemia in Spain Sandra Merino-Montero Received Received
  319-EE Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA Patricia Homar Received Received
  320-HTA The Impact of Using England Real-World Evidence to Establish the NICE Severity Modifier in Metastatic Urothelial Carcinoma mUC Will Perkin Received Received
  321-HTA The Interim Acceptance and Ultra-Orphan Pathways in Scotland: An Update Ethan Prince Received Received
  322-HTA The Key Role of Social Participation in Health Technology Assessment: Experiences From South American Countries Vania Cristina Canuto Santos Received Received
  323-HTA The Landscape of the Use of Artificial Intelligence and Machine Learning AIMI Methods in Health Technology Assessment HTA Submissions Ins Guerra Received Received
  326-EE Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes Joshua Weinstein Received Received
  326-HTA The Phantom Menace: How Consultations and Appeals During NICE HST Appraisals Contribute to Delays in Patient Access Bersabhe Solomon Received Received
  328-HTA The Rise of Optimisation in NICE Guidance: A Two-Decade Review With a Focus on Prevention Rachel Barr-Keenan Received Received
  341-EE Does Insurance Value in Metastatic Breast Cancer Vary by Age Testing for Variation in Willingness to Pay for Novel Treatments Among Women in the US Jaehong Kim Received Received
  344-EE Drivers of Inpatient Costs in Oncology Patients Undergoing Major Abdominal Surgery: Evidence from a Middle-Income Country Jorge Alexis Medina Parra Received Received
  349-EE Economic and Antibiotic Benefits of Vonoprazan-Based Regimens for First-Line Helicobacter Pylori Eradication in China Yanan Sheng Received Received
  350-EE Economic and Clinical Impact of Older Adult Vaccination with The Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico Rengina Kefalogianni Received Received
  353-EE Economic Burden and Health Related Quality of Life Associated With Schizophrenia in Saudi Arabia Ahmed Alghamdi Received Received
  356-HTA Viable Reimbursement and Financing Models for mHealth Interventions in Sub-Saharan Africa: A Narrative Review Gareth Obery Received Received
  362-HTA What Drives European Union (EU) Health Technology Assessment (HTA) Decisions in Melanoma? A Targeted Review on Clinical Evidence Critiques Emily Morton-West Received Received
  368-HTA When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-level Evidence Andrea Berardi Received Received
  379-EE Economic Evaluation of Dinutuximab Beta in the Maintenance Therapy of High-Risk Neuroblastoma in Brazil Fabian Schmidt Received Received
  390-EE Economic Evaluation of the RESET Study Weight Loss Phase: Impact on Event Risk Reduction and Cost-Effectiveness in Type 2 Diabetes Management Bjoern Schwander Received Received
  391-EE Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups Colleen Dumont Received Received
  412-EE Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Sub-study Michaela Barbier Received Received
  419-EE Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS Piaopiao Li Received Received
  427-EE Economic burden of chikungunya in an outbreak setting: A modelling study in Rome and Nice Adrianne de Roo Received Received
  457-EE Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimers Diagnostic Cost-Effectiveness Model Viviana Hernandez Received Received
  478-EE Foregone Net Monetary Benefit From Underdiagnosis and Undertreatment of Mild Cognitive Impairment Due to Alzheimer´s Disease in the Medicare Population Scott Johnson Received Received
  483-EE Has the IRA Impacted International Price Differentials? Comparing US and German Drug Prices in the Era of MFP Loukia Mantzali Received Received
  502-EE Healthcare Expenditure for Treatment of Cardiovascular Disease Among Hypercholesterolemia Patients in Japan: A Claims Data Analysis Tomohiro Kondo Received Received
  517-EE Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan Jade Garratt-Wheeldon Received Received
  519-EE Hereditary Transthyretin Amyloidosis (ATTRv) Below the Age of 70 Healthcare Resource Utilization and Mortality Klas Rikner Received Received
  540-EE Impact of Proteinuria and Declining Kidney Function on the Healthcare Resource Utilization and Associated Costs of Patients With IgA Nephropathy: A Retrospective Analysis in the UK and Spain Antonio Ramirez de Arellano Received Received
  553-EE Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis Deirdre Weymann Received Received
  576-EE Medium vs. Low Citrate Concentration in Continuous Kidney Replacement Therapy: Positive Budget Impact Through Total Cost of Ownership Assessment Marta Medaglia Received Received
  580-EE Microsimulation Model to Estimate the Clinical and Cost Burden of Adverse Events Related to Long-Term Oral Corticosteroid Usage in Autoimmune Diseases in the United States Rachel Meade Received Received
  583-EE Model Structure Variability in NICE HTAs: Evidence From Asthma and TMA Appraisals to Support the Need for Disease-Specific Reference Models Patricia Homar Received Received
  589-EE Modelling the Healthcare Burden of Oral Corticosteroid Use in Mexico Zahava Gabriel Received Received
  590-EE Modelling Treatmentfree Remission Outcomes for Asciminib in Newly Diagnosed Chronic Myeloid Leukaemia: Assumptions Methodology and Projections Shaun Walsh Received Received
  595-EE Obstructive Sleep Apnea (OSA) Phenotypes and the Personalized Impact of Positive Airway Pressure (PAP) Therapy on Healthcare Resource Use MELIKE DEGER WEHR Received Received
  599-EE Optimization of the EVAR Pathway: An Integrated Organizational Model for Clinical Efficiency and Economic Sustainability Elisa Tacconi Received Received
  606-EE Patient Blood Management With Intravenous Iron Is Economically Advantageous Compared to Usual Care in German Hospitals Mathias Flume Received Received
  613-EE Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population Yifat Fundoiano-Hershcovitz Received Received
  615-EE Price Behavior of Originator Adalimumab After Biosimilars Entry: Evidence From the Colombian Market carolina arias Received Received
  641-EE Reducing External Plasma Dependency: Impact for the Portuguese National Health Service Joana Alves Received Received
  649-EE Requirements for Payer Recognition of Disease-Modifying Effect in New Drug Launches Richard Mee Received Received
  652-EE Review of CEESP ICERs for Orphan and Nonorphan Treatments in France, 2024-2025 Kate Monk Received Received
  656-EE Site of Care Cost-Effectiveness of Axicabtagene Ciloleucel in Relapsed/Refractory Second-Line or Later Large B-cell Lymphoma in the United States: Analyses for Inpatient and Outpatient Infusion Settings Nate Smith Received Received
  662-EE Societal Burden of Specific Learning Disorders With Focus on Secondary Mental Health Problems in Japan Tomoyasu Muto Received Received
  684-EE Technical Validation of Health Economic Models: Is There a Gold Standard? Assessment and Refinement of Current Checklist Tools Viviana Hernandez Received Received
  686-EE THE BROADER ECONOMICS OF CHRONIC SPONTANEOUS URTICARIA CSU IN JAPAN: ASSESSING SOCIETAL AND FISCAL BENEFITS OF NOVEL THERAPIES Nikos Kotsopoulos Received Received
  687-EE The Budget Impact and Time Savings of Introducing Subcutaneously-Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenouslyadministered Nivolumab (NIVO IV) Across Indications in Canada Tomaras Dimitrios Received Received
  693-EE The Cost-Effectiveness of Imlifidase Idefirix® for Desensitisation Treatment of Highly Sensitised Adult Kidney Transplant Patients in Ireland Kate Monkn Received Received
  705-EE The Economic Impact of Time-to-Target-Temperature of Different Surface Cooling Technologies for Temperature Management in Critically Ill Patients: A Systematic Review, Analysis, and Model Timothy Kelly Received Received
  714-EE The Impact of Inflation: A Cost Analysis in the Spanish Pharmaceutical Sector From 2014 to 2023 Teresa Dominguez Received Received
  733-EE Transfusion-related Cost and Time Burden in JAKi-Naïve and JAKi-Experienced Patients With Myelofibrosis Treated With Momelotinib and Ruxolitinib From the SIMPLIFY 1 and 2 Studies: A Brazilian Supplementary Health Perspective Dipika Morgan Received Received
  734-EE Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder Ling Zhang Received Received
  736-EE Treatment Patterns and Healthcare Resource Utilization in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study Amanda Pulfer Received Received
  760-EE DMD in Germany: A Societal Cost Analysis Tobias Hackmann Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
13:06
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ISPOR Europe 2025

 

9 - 12 November Glasgow
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 17/11/2042 TO 17/11/2042
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert